Institution Directory

Clinical trials at Stanford Medicine

Sites in Stanford & Palo Alto, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1368

Shown on this page

Current sort

Live official records

Conditions: Major Depressive Disorder, Epilepsy
Interventions: Intracranial electrodes, TMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cervical Spinal Cord Injury, Tetraplegia
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 9
States / cities: Stanford, California • Miami, Florida • Baltimore, Maryland + 6 more

Conditions: Stroke, Patent Foramen Ovale
Interventions: AMPLATZER™ PFO Occluder; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 1,214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 78
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chandler, Arizona + 63 more

Conditions: Percutaneous Coronary Intervention
Interventions: FFRangio, FFR or NHPR; Device
Lead sponsor: CathWorks Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 1,924 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 43
States / cities: La Jolla, California • Long Beach, California • Los Angeles, California + 34 more

Conditions: Muscular Atrophy, Spinal
Interventions: No Intervention; Other
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 54 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 4
States / cities: Palo Alto, California • Boston, Massachusetts • Cambridge, Massachusetts + 1 more

Conditions: Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder, Incontinence, Urge, Incontinence, Urinary, Incontinence
Interventions: Tolterodine Tartrate ER, Mirabegron, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years and older · Female only
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Palo Alto, California • San Francisco, California

Conditions: Blindness
Interventions: Electrotactile display (BrainPort), Vision-to-sound converter (AI Sight), Sham; Device
Lead sponsor: Stanford University; Other
Eligibility: 8 Years to 85 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Palo Alto, California • Stanford, California

Conditions: Obsessive-Compulsive Disorder
Interventions: 3,4-Methyl enedioxy methamphetamine, Methamphetamine, Cognitive Behavioral Therapy (CBT); Drug · Behavioral
Lead sponsor: Carolyn Rodriguez; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Nutrition, Healthy
Interventions: Food FARMacia Program, Self-directed meal preparation support; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 6 Months and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Stanford, California • New York, New York

Conditions: Obesity and Overweight, Nutrition, Chronic Disease, Diabetes, Pregnancy
Interventions: Self-Management, Community-Based; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 795 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 4
States / cities: Palo Alto, California • Flushing, New York • New York, New York

Conditions: Depression
Interventions: Guanfacine, Sertraline; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Palo Alto, California • Chicago, Illinois

Conditions: Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma
Interventions: ALLO-501A, ALLO-647, Fludarabine, Cyclophosphamide; Genetic · Biological · Drug
Lead sponsor: Allogene Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 24
States / cities: Gilbert, Arizona • Phoenix, Arizona • Duarte, California + 21 more

About this Stanford Medicine institution page

What this page lists: ClinicalTrials.gov records that list Stanford Medicine in Stanford & Palo Alto, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Stanford Medicine

Filter and sort this campus

Live official records

Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans

Nerve Transfer to Improve Function in High Level Tetraplegia

AMPLATZER PFO Occluder Post Approval Study

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

TReating Incontinence for Underlying Mental and Physical Health

Sensory Substitution and Brain Plasticity Following Vision Loss

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

Food FARMacia: Reducing Childhood Obesity in Households With Food Insecurity

CHIME: Comparing Health Interventions for Maternal Equity

ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)

About this Stanford Medicine institution page